Clinical Trials Search Results

Results 731-740 of 743 for your search
Show Search Criteria
Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide
Status: Enrolling by Invitation
Age: 4 to 85 years
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
Status: Enrolling by Invitation
Age: 4 to 85 years
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Biomarker Analysis of Central Nervous System Tumors
Status: Enrolling by Invitation
Age: 99 years and under
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling by Invitation
Age: 100 years and under
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Natural History of Maternal Neoplasia
Status: In Review
Age: 18 years and over
Gender: Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Status: In Review
Age: 18 years and over
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Optimization of Collection Methods for Studies of the Human Microbiota
Status: In Review
Age: 18 to 100 years
Gender: Male or Female
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
Status: Approved
Age: 18 years and over
Gender: Male or Female
Location: Location information is not yet available.
Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate
Status: Approved
Age: 18 years and over
Gender: Male or Female
Location: Eastern Cooperative Oncology Group, Boston, Massachusetts
Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib Hydrochloride
Status: Approved
Age: 18 years and over
Gender: Male or Female
Location: Eastern Cooperative Oncology Group, Boston, Massachusetts